ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
zrod13107
|
3.4K |
1.1M |
6 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
3.4K
|
1.1M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
|
|
zrod13107
|
914 |
286K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
914
|
286K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
zrod13107
|
1.1K |
310K |
13 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
310K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Healthcare Conference Investor Presentation
|
|
zrod13107
|
73 |
41K |
40 |
12/01/21 |
12/01/21 |
ASX - By Stock
|
73
|
41K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
zrod13107
|
763 |
323K |
63 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
323K
|
63
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
zrod13107
|
416 |
130K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
416
|
130K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
zrod13107
|
416 |
130K |
0 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
416
|
130K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
zrod13107
|
796 |
393K |
10 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
393K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
zrod13107
|
796 |
393K |
2 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
393K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
zrod13107
|
796 |
393K |
2 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
393K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
zrod13107
|
796 |
393K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
393K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
zrod13107
|
796 |
393K |
7 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
393K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Guess the opening price - if ARDS halted due supreme efficacy
|
|
zrod13107
|
416 |
130K |
7 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
416
|
130K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
4 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
zrod13107
|
392 |
157K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
392
|
157K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
zrod13107
|
344 |
178K |
3 |
01/11/20 |
01/11/20 |
ASX - By Stock
|
344
|
178K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Notice of Annual General Meeting and Proxy Form
|
|
zrod13107
|
32 |
13K |
8 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
32
|
13K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Notice of Annual General Meeting and Proxy Form
|
|
zrod13107
|
32 |
13K |
3 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
32
|
13K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
zrod13107
|
635 |
275K |
5 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
275K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
zrod13107
|
635 |
275K |
6 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
275K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
5 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
zrod13107
|
161 |
78K |
9 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
161
|
78K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
FDA does not over-rule positive ODAC decisions
|
|
zrod13107
|
161 |
78K |
6 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
161
|
78K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
7 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
0 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
4 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
6 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
7 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
1 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
11 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
3 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
0 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
4 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
9 |
25/09/20 |
25/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Tracking Valuations
|
|
zrod13107
|
322 |
169K |
16 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
322
|
169K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
8 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
zrod13107
|
3.1K |
1.4M |
2 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
New video discussion with Mesoblast CEO
|
|
zrod13107
|
122 |
63K |
30 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
122
|
63K
|
30
|
|
ASX - By Stock
|
MSB Biotech |
Re:
New video discussion with Mesoblast CEO
|
|
zrod13107
|
122 |
63K |
20 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
122
|
63K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
1 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
zrod13107
|
5.0K |
2.4M |
2 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
5.0K
|
2.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
zrod13107
|
13K |
4.9M |
9 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
13K
|
4.9M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
zrod13107
|
2.0K |
681K |
7 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB ODAC MEETING AGENDA TIMES
|
|
zrod13107
|
6 |
1.7K |
0 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
6
|
1.7K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C
|
|
zrod13107
|
248 |
93K |
17 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
248
|
93K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
zrod13107
|
854 |
426K |
24 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
854
|
426K
|
24
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
zrod13107
|
23K |
13M |
1 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
zrod13107
|
23K |
13M |
5 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
zrod13107
|
23K |
13M |
1 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
zrod13107
|
23K |
13M |
11 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
23K
|
13M
|
11
|
|